Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,056 | 11,609 | 23,177 | 41,786 | 67,325 |
| Receivables | 3,351 | 3,228 | 1,812 | N/A | N/A |
| TOTAL | $17,467 | $16,281 | $27,403 | $45,520 | $68,858 |
| Non-Current Assets | |||||
| PPE Net | 222 | 270 | 422 | 345 | 101 |
| Intangibles | 0 | 0 | 5,700 | 5,525 | 0 |
| Other Non-Current Assets | 20,550 | 18,801 | 21,694 | 20,471 | 1,406 |
| TOTAL | $20,772 | $19,071 | $27,816 | $26,341 | $1,507 |
| Total Assets | $38,239 | $35,352 | $55,219 | $71,861 | $70,365 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,014 | 859 | 770 | 915 | 524 |
| Accrued Expenses | 6,719 | 4,512 | 4,512 | 2,899 | 2,906 |
| Other current liabilities | N/A | N/A | N/A | 2,973 | N/A |
| TOTAL | $10,014 | $7,585 | $6,738 | $7,060 | $3,554 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,671 | 92 | 162 | 221 | N/A |
| Other Non-Current Liabilities | 11,171 | 8,608 | 10,450 | 11,132 | 1,404 |
| TOTAL | $12,842 | $8,700 | $11,518 | $12,971 | $1,403 |
| Total Liabilities | $22,856 | $16,285 | $18,256 | $20,031 | $4,957 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 45,893 | 2,782 | 686 | 605 | 634 |
| Common Shares | 34 | 3 | 1 | 16 | 13 |
| Retained earnings | -358,710 | -334,971 | -309,318 | -290,969 | -271,284 |
| Other shareholders' equity | 467 | -1,466 | -256 | -967 | 0 |
| TOTAL | $15,383 | $19,067 | $36,963 | $51,830 | $65,408 |
| Total Liabilities And Equity | $38,239 | $35,352 | $55,219 | $71,861 | $70,365 |